Recent News

• 03.04.2026 - Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
• 02.25.2026 - Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering

Recent Filings

• 03.02.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2026 - 8-K Current report
• 02.26.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 02.25.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 02.24.2026 - 8-K Current report
• 02.24.2026 - EX-99.1 EX-99.1